{"id":812560,"date":"2025-02-13T06:05:52","date_gmt":"2025-02-13T11:05:52","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/"},"modified":"2025-02-13T06:05:52","modified_gmt":"2025-02-13T11:05:52","slug":"verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/","title":{"rendered":"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">LONDON and RALEIGH, N.C., Feb.  13, 2025  (GLOBE NEWSWIRE) &#8212; Verona Pharma plc (Nasdaq: VRNA) (\u201cVerona Pharma\u201d or the \u201cCompany\u201d) announces that it will report its financial results for the fourth quarter and full year ended December 31, 2024 on Thursday, February 27, 2025 and host an investment community conference call at 9:00 a.m. EST \/ 2:00 p.m. GMT to discuss these financial results and provide a corporate update.<\/p>\n<p align=\"justify\">To participate, please dial one of the following numbers and ask to join the Verona Pharma call:<\/p>\n<ul type=\"disc\">\n<li style=\"text-align:justify\">+1-800-836-8184 for callers in the United States<\/li>\n<li style=\"margin-bottom:6pt;text-align:justify\">+1-646-357-8785 for international callers<\/li>\n<\/ul>\n<p align=\"justify\">A live webcast will be available on the Events and Presentations link on the Investors page of the Company\u2019s website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RzXE1Xpyo0SKZWEwxOXyOv-hCE9FWGv5WB9ABod6YhukjNgaJgmP0hh_1Opk5eY3zR1N2Ydnz43kIENvxgmFj4OfTloK3q_LHo4k31tFpMo=\" rel=\"nofollow\" target=\"_blank\">www.veronapharma.com<\/a>, and the audio replay will be available for 90 days.<\/p>\n<p>For further information please contact:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:60%;width:60%;min-width:60%;vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Verona Pharma plc<\/strong>\n          <\/td>\n<td style=\"max-width:40%;width:40%;min-width:40%;vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Tel: +1-844-341-9901<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Victoria Stewart, Senior Director of Investor Relations and Communications<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <a href=\"mailto:IR@veronapharma.com\" rel=\"nofollow\" target=\"_blank\">IR@veronapharma.com<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Argot Partners<\/strong><br \/>\n            <br \/>US Investor Enquiries<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Tel: +1-212-600-1902<br \/><a href=\"mailto:verona@argotpartners.com\" rel=\"nofollow\" target=\"_blank\">verona@argotpartners.com<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\n            <strong>Ten Bridge Communications<\/strong><br \/>\n            <br \/>International \/ US Media Enquiries<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Tel: +1-781-316-4424<br \/><a href=\"mailto:tbcverona@tenbridgecommunications.com\" rel=\"nofollow\" target=\"_blank\">tbcverona@tenbridgecommunications.com<\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">Wendy Ryan<\/td>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong><br \/>\n          <br \/>About Verona Pharma<\/strong>\n      <\/p>\n<p align=\"justify\">Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. Ohtuvayre<sup>TM<\/sup> (ensifentrine) is the Company\u2019s first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Ensifentrine has potential applications in non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma and other respiratory diseases. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RzXE1Xpyo0SKZWEwxOXyOv-hCE9FWGv5WB9ABod6YhuA1jXG64dsW4sZu1TjhU0Gu86S5_7CoFiLmtKaC2dXv6BDtrqGZ06ogTAmCx7B6lrrjP6Rp2IGGPL6ERIVt8qSMcwhVi5MmTfHx3cFgpaxkt7KpBJSiLziKbFY48tZ0hRI38Sn-mBbXt3DoYI6f53glYBrBBJ8Sa5mi7nCdACtPedHm9KjPpaEBngWabRryoSUIrhBs-J_jQeFIi0krWGa1hl0Xu_MWT4iKvKa6yxKQeExufXLnrkDofSgHyMcAJuqOC6FZxtJd96LRn-6IAl7Ho3QAafSB6oimDksyza4q7qkN_cOPrM15kDb26qOta_vBO10uRbiXtd2GW8ZdgGZrehCRTcCcOAojNpQH7zSnIbDf4f_zff9w_xF2xsB4318LjTjPFzxiw1QPWT3GY8Mh3im8dB6pt3OgZEbKT_IYk_uT0G7MWo2TSiEqdVy9Dc=\" rel=\"nofollow\" target=\"_blank\">www.veronapharma.com<\/a>.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YTU2ZDZjNDAtYWUyYS00OWQzLTk3YmQtY2Q3MzllNzQ0YjY2LTEwOTU5MzE=\/tiny\/Verona-Pharma-plc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON and RALEIGH, N.C., Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Verona Pharma plc (Nasdaq: VRNA) (\u201cVerona Pharma\u201d or the \u201cCompany\u201d) announces that it will report its financial results for the fourth quarter and full year ended December 31, 2024 on Thursday, February 27, 2025 and host an investment community conference call at 9:00 a.m. EST \/ 2:00 p.m. GMT to discuss these financial results and provide a corporate update. To participate, please dial one of the following numbers and ask to join the Verona Pharma call: +1-800-836-8184 for callers in the United States +1-646-357-8785 for international callers A live webcast will be available on the Events and Presentations link on the Investors page of the Company\u2019s website, www.veronapharma.com, and the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-812560","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON and RALEIGH, N.C., Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Verona Pharma plc (Nasdaq: VRNA) (\u201cVerona Pharma\u201d or the \u201cCompany\u201d) announces that it will report its financial results for the fourth quarter and full year ended December 31, 2024 on Thursday, February 27, 2025 and host an investment community conference call at 9:00 a.m. EST \/ 2:00 p.m. GMT to discuss these financial results and provide a corporate update. To participate, please dial one of the following numbers and ask to join the Verona Pharma call: +1-800-836-8184 for callers in the United States +1-646-357-8785 for international callers A live webcast will be available on the Events and Presentations link on the Investors page of the Company\u2019s website, www.veronapharma.com, and the &hellip; Continue reading &quot;Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-13T11:05:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update\",\"datePublished\":\"2025-02-13T11:05:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/\"},\"wordCount\":276,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/\",\"name\":\"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=\",\"datePublished\":\"2025-02-13T11:05:52+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/","og_locale":"en_US","og_type":"article","og_title":"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - Market Newsdesk","og_description":"LONDON and RALEIGH, N.C., Feb. 13, 2025 (GLOBE NEWSWIRE) &#8212; Verona Pharma plc (Nasdaq: VRNA) (\u201cVerona Pharma\u201d or the \u201cCompany\u201d) announces that it will report its financial results for the fourth quarter and full year ended December 31, 2024 on Thursday, February 27, 2025 and host an investment community conference call at 9:00 a.m. EST \/ 2:00 p.m. GMT to discuss these financial results and provide a corporate update. To participate, please dial one of the following numbers and ask to join the Verona Pharma call: +1-800-836-8184 for callers in the United States +1-646-357-8785 for international callers A live webcast will be available on the Events and Presentations link on the Investors page of the Company\u2019s website, www.veronapharma.com, and the &hellip; Continue reading \"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-13T11:05:52+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update","datePublished":"2025-02-13T11:05:52+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/"},"wordCount":276,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/","name":"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=","datePublished":"2025-02-13T11:05:52+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1NzI5NCM2NzQ2MTYzIzIwODQzNjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/verona-pharma-to-report-fourth-quarter-and-full-year-2024-financial-results-and-provide-corporate-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/812560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=812560"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/812560\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=812560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=812560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=812560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}